nanoBioSciences, LLC (DBA AdminMed) has developed the Advanced micro-needle Patch (AdminPatch®) technology allowing the delivery of numerous drugs including proteins and water-soluble molecules through the skin. We have received several patents covering design, manufacture, and use of AdminPatch® technology and we are currently working to commercialize it.  Our developed microneedle technology is protected by 3 Granted US Patents (US 7658728, US 7785301, and US 8,414,548) as well as several pending international patents.  Also our AdminPatch® Trademark is granted: (US 77/055420).        

On the basis of AdminPatch® microneedle technology, we developed a painless intradermal and subcutaneous injection device (“AdminPen™”) allowing more effective and painless injection of immunotherapies, vaccines, any liquid pharmaceutical drugs, and cosmetics uniformly into 1cm2 area of the skin. AdminPen has been used to improve the efficacy of a cancer nanoparticle immunotherapeutic several times (4-16 times!) in comparison to the same immunotherapeutic injected using a traditional needle and syringe. AdminPen can be used with any standard commercially available pen with a pre-filled drug cartridge or with any standard commercially available syringe.

AdminPatch® Microneedle Array (left) and AdminPen Microneedle Array injection device (right)

Our AdminMed division is working on commercialization of the developed microneedle technology.  For more information and to purchase product samples please click on the following picture to visit AdminMed.com web-site:

Please also feel free to for more information.